Effect of Bushen Qianggu Fang on serum TRACP5b expression in patients with primary osteoporosis
Objective To investigate the effect of Bushen Qianggu Fang on serum TRACP5b expression in patients with primary osteoporosis. Methods A total of 60 patients with primary osteoporosis were selected from January 2015 to July 2017. The patients were divided into two groups: the treatment group and the control group. The treatment group was treated with oral Calcium D tablet + Bushen Qianggu fang treatment. The control group was treated with oral Erqi D film and Fu Shanmei tablet for 3 months. TCM symptom score, bone mineral density, pain score, fracture risk assessment, TRACP5b. Results ①After 3 months of treatment, the symptoms in the treatment group were significantly improved compared with the control group (P<0.05). ② Followed up for 6 months,the bone mineral density of the treatment group was significantly improved compared with the control group (P<0.05). After 2 months and 3 months, the pain score and the risk assessment of the treatment group and the serum TRACP5b in the treatment group were significantly improved compared with the control group (P<0.05) .Conclusion Bushen Qiangguang Fang can effectively relieve the clinical symptoms of patients, Inhibit excessive bone turnover, so that bone metabolism to achieve a new balance, improve bone mass.
Bushen Qianggu fangprimary osteoporosistartrate-resistant acid phosphatase 5 b
NETL
NSTL
万方数据
维普
